Clinical outcomes of intravenous levetiracetam treatment in patients with renal impairment

• Glavni autori: Anyamanee Lapmag (Autor), Sunee Lertsinudom (Autor), Aporanee Chaiyakam (Autor), Kittisak Sawanyawisuth (Autor), Somsak Tiamkao (Autor)
• Format: Knjiga
• Izdano: MDPI AG, 2018-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Intravenous levetiracetam has been approved for use as an antiepileptic drug, as well as in cases of status epilepticus. There are few reports that detail the clinical data and outcomes associated with this antiepileptic drug, particularly in patients with renal impairment. This was a retrospective...